Voyager Acquisition Corp. (VACHW)

NASDAQ: VACHW · Real-Time Price · USD · Warrants
0.00
0.00 (0.00%)
May 26, 2026, 4:00 PM EDT - Market closed
Market Cap61.51M -81.0%
Revenue (ttm)n/a
Net Income6.74M +117.1%
EPS0.22 +10.8%
Shares Out 6.41M
PE Ratio9.13
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume41
Open0.1800
Previous Close0.1799
Day's Range0.1750 - 0.1850
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About VACHW

Voyager Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the healthcare or healthcare related sectors. Voyager Acquisition Corp. was incorporated in 2023 and is based in Brooklyn, New York.

Sector Financials
Founded 2023
Country United States
Stock Exchange NASDAQ
Ticker Symbol VACHW
Full Company Profile

News

Voyager Acquisition Corp trading resumes

09:37 EDT Voyager Acquisition (VACH) Corp trading resumes

12 days ago - TheFly

Voyager Acquisition Corp trading halted, volatility trading pause

09:32 EDT Voyager Acquisition (VACH) Corp trading halted, volatility trading pause

12 days ago - TheFly

Voyager Acquisition Corp trading halted, volatility trading pause

13:55 EDT Voyager Acquisition (VACH) Corp trading halted, volatility trading pause

13 days ago - TheFly

Voyager Acquisition Corp trading resumes

14:00 EDT Voyager Acquisition (VACH) Corp trading resumes

13 days ago - TheFly

Voyager Acquisition Corp trading halted, volatility trading pause

14:28 EDT Voyager Acquisition (VACH) Corp trading halted, volatility trading pause

14 days ago - TheFly

Voyager Acquisition Corp trading resumes

14:33 EDT Voyager Acquisition (VACH) Corp trading resumes

14 days ago - TheFly

Voyager Acquisition Corp trading halted, volatility trading pause

11:07 EDT Voyager Acquisition (VACH) Corp trading halted, volatility trading pause

5 weeks ago - TheFly

Voyager Acquisition Corp trading resumes

11:12 EDT Voyager Acquisition (VACH) Corp trading resumes

5 weeks ago - TheFly

Voyager Acquisition Corp trading resumes

13:07 EDT Voyager Acquisition (VACH) Corp trading resumes

5 weeks ago - TheFly

Voyager Acquisition Corp trading halted, volatility trading pause

13:02 EDT Voyager Acquisition (VACH) Corp trading halted, volatility trading pause

5 weeks ago - TheFly

Voyager Acquisition Corp trading resumes

09:49 EDT Voyager Acquisition (VACH) Corp trading resumes

2 months ago - TheFly

Voyager Acquisition Corp trading halted, volatility trading pause

09:44 EDT Voyager Acquisition (VACH) Corp trading halted, volatility trading pause

2 months ago - TheFly

Voyager Acquisition Corp trading resumes

09:37 EDT Voyager Acquisition (VACH) Corp trading resumes

2 months ago - TheFly

Voyager Acquisition Corp trading halted, volatility trading pause

09:32 EDT Voyager Acquisition (VACH) Corp trading halted, volatility trading pause

2 months ago - TheFly

Voyager Acquisition 22M unit IPO priced at $10.00

Cantor is sole book-running manager.

2 months ago - TheFly

Voyager Acquisition announces approval of combination with Veraxa Biotech

Voyager Acquisition (VACH) held the general meeting on March 12 and approved the previously announced business combination with Veraxa Biotech. After the closing of the Business Combination, it is exp...

2 months ago - TheFly

Voyager Acquisition Corporation Announces Approval of Its Business Combination with Veraxa Biotech AG

BROOKLYN, N.Y., March 13, 2026 (GLOBE NEWSWIRE) -- Voyager Acquisition Corporation (NASDAQ: “VACHU,” “VACH,” “VACHW”) (“Voyager” or the “Company”) held the general meeting on March 12, 2026 and approv...

2 months ago - GlobeNewsWire

Voyager Acquisition Corp trading resumes

09:57 EDT Voyager Acquisition (VACH) Corp trading resumes

2 months ago - TheFly

Voyager Acquisition Corp trading halted, volatility trading pause

09:52 EDT Voyager Acquisition (VACH) Corp trading halted, volatility trading pause

2 months ago - TheFly

Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG

BROOKLYN, N.Y., March 11, 2026 (GLOBE NEWSWIRE) -- Voyager Acquisition Corporation (NASDAQ: “VACHU,” “VACH,” “VACHW”) (“Voyager” or the “Company”) today announced that holders of 25,217,315 of the Com...

2 months ago - GlobeNewsWire

VERAXA Biotech Shareholders Approve Merger and Issuance of New Shares to Voyager Acquisition Corp.

VERAXA shareholders approve merger & issuance of new shares to Voyager. Both resolutions are prerequisites for the closing of the business combination.

3 months ago - GlobeNewsWire

VERAXA Biotech and Secarna Pharmaceuticals Initiate Antibody Oligonucleotide Conjugate Alliance in Immunology

Partnership combines Secarna's OligoCreator® platform with VERAXA's technology suite to create next-generation targeted therapies for autoimmune and inflammatory diseases Partnership combines Secarna'...

8 months ago - GlobeNewsWire

Voyager Acquisition, VERAXA announce filing of Form F-4 registration statement

VERAXA Biotech and Voyager Acquisition (VACH) Corp. announced today the filing of a registration statement on Form F-4, which includes a preliminary proxy statement, with the U.S. Securities and Excha...

11 months ago - TheFly

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC

ZURICH, July 17, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA” or the "Company"), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp.,  a Cayman Islands exempt...

11 months ago - GlobeNewsWire

VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform

VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Advisor, and Hosting Meetings with Potential Partners and Investors VERAXA Attending ASCO and BIO with...

1 year ago - GlobeNewsWire